Bayogbog, Reynaldo M.
HRN: 25-81-32 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/04/2024
09/10/2024
IVT
2g
Q6
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes